COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

NYSE:CRBD • US21871X2080

24.37 USD
+0.03 (+0.12%)
Last: Feb 12, 2026, 08:04 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CRBD. CRBD was compared to 96 industry peers in the Financial Services industry. CRBD may be in some trouble as it scores bad on both profitability and health. CRBD is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CRBD was profitable.
  • In the past year CRBD had a positive cash flow from operations.
  • CRBD had positive earnings in 4 of the past 5 years.
  • CRBD had a positive operating cash flow in 4 of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

  • CRBD's Return On Assets of 0.24% is on the low side compared to the rest of the industry. CRBD is outperformed by 66.67% of its industry peers.
  • With a Return On Equity value of 7.32%, CRBD perfoms like the industry average, outperforming 42.71% of the companies in the same industry.
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROIC N/A
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

  • With a Profit Margin value of 5.64%, CRBD perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CRBD has grown nicely.
  • CRBD has a Operating Margin (12.90%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CRBD has grown nicely.
Industry RankSector Rank
OM 12.9%
PM (TTM) 5.64%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1

2. Health

2.1 Basic Checks

  • CRBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for CRBD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

  • The Debt to FCF ratio of CRBD is 6.80, which is on the high side as it means it would take CRBD, 6.80 years of fcf income to pay off all of its debts.
  • CRBD has a Debt to FCF ratio of 6.80. This is comparable to the rest of the industry: CRBD outperforms 54.17% of its industry peers.
  • CRBD has a Debt/Equity ratio of 0.81. This is a neutral value indicating CRBD is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CRBD (0.81) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Altman-Z N/A
ROIC/WACCN/A
WACC7.78%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

  • CRBD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.89%.
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.80% on average over the next years. This is quite good.
  • CRBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.51% yearly.
EPS Next Y13.8%
EPS Next 2Y15.97%
EPS Next 3Y12.32%
EPS Next 5Y11.8%
Revenue Next Year8.11%
Revenue Next 2Y7.76%
Revenue Next 3Y5.76%
Revenue Next 5Y5.51%

3.3 Evolution

CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.19, which indicates a rather cheap valuation of CRBD.
  • Based on the Price/Earnings ratio, CRBD is valued cheaper than 94.79% of the companies in the same industry.
  • CRBD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.67.
  • The Price/Forward Earnings ratio is 4.56, which indicates a rather cheap valuation of CRBD.
  • CRBD's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRBD is cheaper than 94.79% of the companies in the same industry.
  • CRBD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.69.
Industry RankSector Rank
PE 5.19
Fwd PE 4.56
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRBD indicates a somewhat cheap valuation: CRBD is cheaper than 71.88% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CRBD is valued cheaply inside the industry as 82.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.83
EV/EBITDA 8.62
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CRBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CRBD's earnings are expected to grow with 12.32% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y15.97%
EPS Next 3Y12.32%

3

5. Dividend

5.1 Amount

  • CRBD has a Yearly Dividend Yield of 3.21%.
  • CRBD's Dividend Yield is a higher than the industry average which is at 2.03.
  • Compared to an average S&P500 Dividend Yield of 1.80, CRBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.21%

5.2 History

  • CRBD is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • CRBD pays out 52.57% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP52.57%
EPS Next 2Y15.97%
EPS Next 3Y12.32%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBD Dividend Payout.CRBD Dividend Payout, showing the Payout Ratio.CRBD Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (2/12/2026, 8:04:00 PM)

24.37

+0.03 (+0.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners85.7%
Inst Owner ChangeN/A
Ins Owners0.26%
Ins Owner ChangeN/A
Market Cap12.68B
Revenue(TTM)N/A
Net Income(TTM)991.00M
Analysts78.1
Price Target29.59 (21.42%)
Short Float %0.01%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 3.21%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP52.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.88%
Min EPS beat(2)-13.79%
Max EPS beat(2)15.55%
EPS beat(4)2
Avg EPS beat(4)0.49%
Min EPS beat(4)-13.79%
Max EPS beat(4)15.55%
EPS beat(8)6
Avg EPS beat(8)3.22%
EPS beat(12)9
Avg EPS beat(12)5.86%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.16%
Min Revenue beat(2)-11.42%
Max Revenue beat(2)15.74%
Revenue beat(4)1
Avg Revenue beat(4)-5.62%
Min Revenue beat(4)-14.87%
Max Revenue beat(4)15.74%
Revenue beat(8)2
Avg Revenue beat(8)-14.47%
Revenue beat(12)4
Avg Revenue beat(12)-10.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.53%
PT rev (3m)-7.06%
EPS NQ rev (1m)-2.89%
EPS NQ rev (3m)-6.14%
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-9.75%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)2.81%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)4.26%
Valuation
Industry RankSector Rank
PE 5.19
Fwd PE 4.56
P/S 0.72
P/FCF 7.83
P/OCF 7.83
P/B 0.94
P/tB 0.94
EV/EBITDA 8.62
EPS(TTM)4.7
EY19.29%
EPS(NY)5.35
Fwd EY21.95%
FCF(TTM)3.11
FCFY12.76%
OCF(TTM)3.11
OCFY12.76%
SpS33.78
BVpS26.02
TBVpS26.02
PEG (NY)0.38
PEG (5Y)N/A
Graham Number52.45
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.9%
PM (TTM) 5.64%
GM N/A
FCFM 9.21%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Debt/EBITDA 4.06
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.58
Cash Conversion 59.72%
Profit Quality 163.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
EPS Next Y13.8%
EPS Next 2Y15.97%
EPS Next 3Y12.32%
EPS Next 5Y11.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.42%
Revenue Next Year8.11%
Revenue Next 2Y7.76%
Revenue Next 3Y5.76%
Revenue Next 5Y5.51%
EBIT growth 1Y291.07%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-5.93%
EBIT Next 3Y-0.33%
EBIT Next 5YN/A
FCF growth 1Y-47.72%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-47.72%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 / CRBD FAQ

Can you provide the ChartMill fundamental rating for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a fundamental rating of 3 / 10 to CRBD.


What is the valuation status of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

ChartMill assigns a valuation rating of 8 / 10 to COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD). This can be considered as Undervalued.


What is the profitability of CRBD stock?

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) has a profitability rating of 3 / 10.


What is the valuation of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 5.19 and the Price/Book (PB) ratio is 0.94.


What is the financial health of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The financial health rating of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 1 / 10.